Related Experiment Video
Updated: Jul 14, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
[Renal and cardiac functions as prognostic factors after revascularization for myocardial infarction]
R Reibis1, J Herbstleb, W Kamke
1Klinik am See, Fachklinik für Innere Medizin, Rüdersdorf b. Berlin, Germany. rona.reibis@hotmail.de <rona.reibis@hotmail.de>
Insights
Prognosis after myocardial infarction reperfusion is influenced by left ventricular ejection fraction (LVEF), left bundle branch block, and renal function. These factors significantly impact patient survival post-treatment.
Area of Science:
- Cardiology
- Clinical Medicine
- Medical Research
Context:
- Optimal treatment for myocardial infarction (MI) involves reperfusion therapies and secondary prevention.
- Prognostic factors following MI treatment remain an area of active investigation.
- Understanding post-MI prognosis is crucial for patient management and risk stratification.
Purpose:
- To identify key factors influencing patient prognosis after myocardial infarction (MI) reperfusion therapy.
- To analyze the impact of various clinical parameters on mortality and adverse events post-MI.
- To determine predictors of long-term outcomes in patients undergoing revascularization for MI.
Summary:
- A prospective multicenter registry study followed 926 patients post-MI revascularization.
- Left ventricular ejection fraction (LVEF), left bundle branch block, and elevated serum creatinine were significant predictors of mortality.
- Conventional risk factors and prior treatments did not significantly influence outcomes.
Impact:
- Identifies critical indicators for assessing mortality risk in post-MI patients.
- Highlights the importance of LVEF, renal function, and conduction abnormalities in prognosis.
- Informs clinical decision-making and patient counseling regarding long-term outcomes after MI.
Background And Objective:
In the last few decades optimal treatment of myocardial infarction has been achieved by thrombolytic and interventional reperfusion as well as subsequent secondary pharmacological prevention. It remains a subject of debate what factors influence prognosis after such measures.
Patients And Methods:
939 patients who had sustained acute myocardial infarction (75.1% males, aged 62.5 10.1 years) were followed prospectively after revascularization, using a multicenter registry (PreSCD) registry. Date and site of infarction, reperfusion measures, cardiovascular risk factors, hemoglobin and creatinine, QRS duration, ventricular arrhythmias recorded by Holter ECG monitoring were recorded, as well as biplane left ventricular ejection fraction (LVEF). Multivariate logistic Cox regression analysis was used to determine the effect of these various factors on overall mortality, resuscitation outcome, ventricular tachycardia, re-infarction, syncope and interventional or surgical revascularization.
Results:
Complete data were collected on 926 patients (98.6%). During the follow-up period of 578 47 days there were 39 deaths (4.2%), 29 of them due to cardiac reasons, predominantly sudden cardiac death (58.6%). The occurrence of left bundle branch block was associated overall with a sevenfold increase in the of death (hazard ratio [95% confidence interval, (CI) 6.940 (2.912-16.539); p<0.0001), while an increase of serum creatinine by 1 mol/l raised the overall mortality by 0.7% (Hazard ratio (95% CI) 1.007 (1.03-1.012); p<0.001]. Improvement of LVEF by 1 % was associated with a 5% reduction in mortality risk (Hazard ratio [95% CI] 0.946 (0.918-0.975); p<0.0001]. Conventional cardiovascular risk factors, previous revascularization measures, site of infarction and pharmacological treatment failed to show any significant influence on end-points.
Conclusion:
In patients who had revascularization measures after a myocardial infarction the mortality rate was less than 5%. The risk of death was determined by LVEF, occurrence of left bundle branch block and renal failure.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pathophysiology of Heart Failure
Acute Coronary Syndrome III: Diagnostic Studies
Pathophysiology of Cardiac Performance
Myocarditis III: Medical Management
